Loading the player ...
Mark Mercola and Robert Kass discuss their collaborative work screening existing drugs to treat long QT syndrome. Their collaboration combines Dr. Kass's expertise in the pathology of long QT syndrome with Dr. Mercola's research on a high throughput drug screening infrastructure, evaluating how different drugs impact cell properties, using cells derived from human induced pluripotent stem cells, in this case, cardiac cells.
Mark Mercola is Professor of Department of Bioengineering at the Jacobs School of Engineering, UC San Diego and the Professor and Director of the Muscle Development and Regeneration Program, Sanford-Burnham Medical Research Institute (SBMRI).
Robert Kass is Vice Dean for Research, Alumni and Hosack Professor of Pharmacology & Chair at Columbia University Medical Center.